Search results
Results from the WOW.Com Content Network
This is a partial list of herbs and herbal treatments with known or suspected adverse effects, either alone or in interaction with other herbs or drugs. Non-inclusion of an herb in this list does not imply that it is free of adverse effects.
When two drugs affect each other, it is a drug–drug interaction (DDI). The risk of a DDI increases with the number of drugs used. [1] A large share of elderly people regularly use five or more medications or supplements, with a significant risk of side-effects from drug–drug interactions. [2] Drug interactions can be of three kinds ...
The ConsensusPathDB is a molecular functional interaction database, integrating information on protein interactions, genetic interactions signaling, metabolism, gene regulation, and drug-target interactions in humans. ConsensusPathDB currently (release 30) includes such interactions from 32 databases. [1]
Artemisia douglasiana or California mugwort, Douglas's sagewort or dream plant, is a western North American species of aromatic herb in the sunflower family that can be used as a scent, tea, or smoke to trigger vivid and lucid dreams. [citation needed] Artemisia vulgaris; Wild red asparagus root may promote dreams that involve flying. [citation ...
Version 4.17 (May 2024) of PHI-base [1] provides information on 9973 genes from 296 pathogens and 249 hosts and their impact on 22415 interactions as well on efficacy information on ~20 drugs and the target sequences in the pathogen. PHI-base currently focuses on plant pathogenic and human pathogenic organisms including fungi, oomycetes, and ...
Launched in July 2001 under the name EcstasyData, its purpose was to collect ecstasy pill samples sent anonymously by the public, in order to manage, review, and publicly report laboratory test results from a variety of organizations [28] As the site evolved into DrugsData, the service expanded to testing samples of most recreational drugs, and ...
The Comparative Toxicogenomics Database (CTD) is a public website and research tool launched in November 2004 that curates scientific data describing relationships between chemicals/drugs, genes/proteins, diseases, taxa, phenotypes, GO annotations, pathways, and interaction modules. The database is maintained by the Department of Biological ...
The MHRA and the US Food and Drug Administration were criticised in the 2012 book Bad Pharma, [43] and in 2004 by David Healy in evidence to the House of Commons Health Committee, [44] for having undergone regulatory capture, i.e. advancing the interests of the drug companies rather than the interests of the public.